Patents/Inventors

Xiaozhao Wang

Mt. Laurel, NJUS26 patents

22 Patents

US126007172026
Tricyclic Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US126007222026
Tetracyclic Compounds as DGK Inhibitors
Incyte Corporation
0 cites
US126007232026
Tetracyclic Compounds as DGK Inhibitors
Incyte Corporation
0 cites
US124417272025
Tricyclic Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US124417422025
Naphthyridine Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US124158092025
Pyrrolotriazine Compounds as Tam Inhibitors
Incyte Corporation
0 cites
US123782432025
Quinoline Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US123310632025
Hetero-bicyclic Inhibitors of KRAS
Incyte Corporation
0 cites
US120775392024
Imidazole and Triazole KRAS Inhibitors
Incyte Corporation
0 cites
US120604332024
CD73 Inhibitor and A2A/A2B Adenosine Receptor Inhibitor Combination Therapy
Incyte Corporation
0 cites
US120308832024
Hetero-tricyclic Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US120308842024
Pyrazoloquinoline KRAS Inhibitors
Incyte Corporation
0 cites
US119997402024
Fused Pyrazine Derivatives as A2A / A2B Inhibitors
Incyte Corporation
0 cites
US119997522024
Vinyl Imidazole Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US119760732024
Bicyclic Amines as CDK2 Inhibitors
Incyte Corporation
0 cites
US119393282024
Quinoline Compounds as Inhibitors of KRAS
Incyte Corporation
0 cites
US118846652024
Pyrazolopyridines and Triazolopyridines as A2A / A2B Inhibitors
Incyte Corporation
0 cites
US118733042024
Fused Pyrimidine Derivatives as A2A/A2B Inhibitors
Incyte Corporation
0 cites
US117673202023
Bicyclic Dione Compounds as Inhibitors of KRAS
INCYTE CORPORATION
0 cites
US117391022023
Fused Pyrimidine Compounds as KRAS Inhibitors
INCYTE CORPORATION
0 cites
US116738942023
Imidazopyrimidines and Triazolopyrimidines as A2A / A2B Inhibitors
Incyte Corporation
0 cites
US115913382023
Pyrrolotriazine Compounds as TAM Inhibitors
Incyte Corporation
0 cites